Core Viewpoint - A securities fraud lawsuit has been filed against CoreWeave, Inc. and its executives, with allegations of misleading investors regarding their ability to meet demand and the risks associated with reliance on a single third-party data center supplier [1][3]. Company Overview - CoreWeave is positioned as an AI hyperscale cloud provider, generating nearly all revenue from long-term contracts for AI infrastructure, with revenue recognition contingent upon the operational status of specialized data centers [2]. Financial Performance and Issues - CoreWeave went public at $40 per share following a significant deal with OpenAI, but faced stock price declines due to infrastructure and supplier constraints, as well as lowered revenue guidance linked to data center delays [2][3]. Legal Context - The lawsuit claims that CoreWeave and its executives materially misled investors by overstating demand capabilities and downplaying risks, which became evident through a failed acquisition and subsequent executive admissions [3]. Investor Eligibility - Investors who purchased CoreWeave common stock between March 28, 2025, and December 15, 2025, and experienced a decline in share value may be eligible to participate in the lawsuit [4]. Next Steps for Investors - The deadline for seeking appointment as lead plaintiff is March 13, 2026, and investors are encouraged to contact Block & Leviton for further information [5]. Whistleblower Information - Individuals with non-public information about CoreWeave are encouraged to assist in the investigation, with potential rewards for whistleblowers who provide original information to the SEC [6]. Legal Representation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following the revelation of financial discrepancies [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Postiwala v. Ardent Health, Inc., and it allows purchasers of Ardent Health securities between July 18, 2024, and November 12, 2025, to seek lead plaintiff status by March 9, 2026 [1][2]. - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable and misrepresented its financial position [3]. Group 2: Allegations Against Ardent Health - Allegations include that Ardent Health's accounts receivable framework allowed for inflated reporting by utilizing a 180-day cliff for uncollectible accounts [3]. - The company reportedly did not maintain sufficient professional malpractice liability insurance and had inadequate reserves to cover increasing claims due to social inflation in the New Mexico market [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in Q3 2025 revenue and a $57.5 million cut in EBITDA guidance, leading to a nearly 34% drop in stock price [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Ardent Health securities during the class period to seek lead plaintiff status, which enables them to direct the lawsuit on behalf of all class members [5]. - Investors are not required to serve as lead plaintiff to share in any potential recovery from the lawsuit [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, being ranked 1 in securing monetary relief for investors in securities class action cases [6].

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating Trip.com Group Limited for potential violations of federal securities laws, specifically concerning losses incurred by investors [1]. Group 1 - The investigation is initiated on behalf of investors who may have lost money on Trip.com Group Limited (NASDAQ: TCOM) [1]. - The investigation focuses on the company's disclosures made on January 14, 2026, regarding its financial performance and potential irregularities [1].

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Limited for alleged fraudulent activities that led to significant stock price manipulation and investor losses during the specified class period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Jayud securities from April 21, 2023, to April 30, 2025 [1][2]. - Allegations include a stock price surge from approximately $1.00 to $8.00 per share in early April 2025, without any fundamental news to justify the increase [3]. - The complaint claims that the price spike was driven by a fraudulent promotion campaign, including social media manipulation and insider selling, followed by a dramatic stock collapse of about 95% on April 2, 2025 [3]. Group 2: Company Information - Jayud Global Logistics Limited is based in Shenzhen, China, and provides cross-border logistics services [2]. - The company is publicly traded on NASDAQ under the ticker symbol JYD [1].

LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR VARONIS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAI ...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bath & Body securities between June 4, 2024 and November 19, 2025, bo ...

If you purchased or otherwise acquired Ardent securities during the Class Period, you may move the Court no later than March 9, 2026 to request appointment as lead plaintiff in this putative class action lawsuit. LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) s ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CoreWeave, Inc. ("CoreWeave†or the "Company†) (NASDAQ: CRWV) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON COREWEAVE, INC. (CRWV), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On July 7, 20. ...

New York, New York--(Newsfile Corp. - January 14, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws.What Happened?On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension secondary to hypercorti ...

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in StubHub Holdings, Inc. ("StubHub Holdings, Inc." or the "Company") (NYSE: STUB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of StubHub Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired StubHub common stock pursuant and/or traceable to the registratio ...